ALAS2, given its fundamental role in heme biosynthesis, could potentially serve as a biomarker for conditions such as X-linked sideroblastic anemia [48], but it is not typically utilized as a blood transcriptional biomarker. This evidence concerns the gene ALAS2 and X-linked sideroblastic anemia 1.